The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Acute Kidney Injury Treatment & Management Market Research Report 2025
Synopsis
KI happens in people who are already sick and in the hospital. People who are in the intensive care unit (ICU) are even more likely than people who are in other units of the hospital to have AKI. This is because people who need to be in the ICU are already very sick.
The global Acute Kidney Injury Treatment & Management market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Acute Kidney Injury Treatment & Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Kidney Injury Treatment & Management.
Report Scope
The Acute Kidney Injury Treatment & Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Kidney Injury Treatment & Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Kidney Injury Treatment & Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun Melsungen AG
Baxter International, Inc.
Asahi Kasei Medical Co., Ltd
Angion Biomedica Corp
AM-Pharma
Quark Pharmaceuticals, Inc
Fresenius Medical Care AG & Co. KGaA
Segment by Type
Prerenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury
Postrenal Acute Kidney Injury
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Kidney Injury Treatment & Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
KI happens in people who are already sick and in the hospital. People who are in the intensive care unit (ICU) are even more likely than people who are in other units of the hospital to have AKI. This is because people who need to be in the ICU are already very sick.
The global Acute Kidney Injury Treatment & Management market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Acute Kidney Injury Treatment & Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Kidney Injury Treatment & Management.
Report Scope
The Acute Kidney Injury Treatment & Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Kidney Injury Treatment & Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acute Kidney Injury Treatment & Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun Melsungen AG
Baxter International, Inc.
Asahi Kasei Medical Co., Ltd
Angion Biomedica Corp
AM-Pharma
Quark Pharmaceuticals, Inc
Fresenius Medical Care AG & Co. KGaA
Segment by Type
Prerenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury
Postrenal Acute Kidney Injury
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acute Kidney Injury Treatment & Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Kidney Injury Treatment & Management Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prerenal Acute Kidney Injury
1.2.3 Intrinsic Renal Acute Kidney Injury
1.2.4 Postrenal Acute Kidney Injury
1.3 Market by Application
1.3.1 Global Acute Kidney Injury Treatment & Management Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acute Kidney Injury Treatment & Management Market Perspective (2019-2030)
2.2 Acute Kidney Injury Treatment & Management Growth Trends by Region
2.2.1 Global Acute Kidney Injury Treatment & Management Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acute Kidney Injury Treatment & Management Historic Market Size by Region (2019-2024)
2.2.3 Acute Kidney Injury Treatment & Management Forecasted Market Size by Region (2025-2030)
2.3 Acute Kidney Injury Treatment & Management Market Dynamics
2.3.1 Acute Kidney Injury Treatment & Management Industry Trends
2.3.2 Acute Kidney Injury Treatment & Management Market Drivers
2.3.3 Acute Kidney Injury Treatment & Management Market Challenges
2.3.4 Acute Kidney Injury Treatment & Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Kidney Injury Treatment & Management Players by Revenue
3.1.1 Global Top Acute Kidney Injury Treatment & Management Players by Revenue (2019-2024)
3.1.2 Global Acute Kidney Injury Treatment & Management Revenue Market Share by Players (2019-2024)
3.2 Global Acute Kidney Injury Treatment & Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acute Kidney Injury Treatment & Management Revenue
3.4 Global Acute Kidney Injury Treatment & Management Market Concentration Ratio
3.4.1 Global Acute Kidney Injury Treatment & Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Kidney Injury Treatment & Management Revenue in 2023
3.5 Acute Kidney Injury Treatment & Management Key Players Head office and Area Served
3.6 Key Players Acute Kidney Injury Treatment & Management Product Solution and Service
3.7 Date of Enter into Acute Kidney Injury Treatment & Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Kidney Injury Treatment & Management Breakdown Data by Type
4.1 Global Acute Kidney Injury Treatment & Management Historic Market Size by Type (2019-2024)
4.2 Global Acute Kidney Injury Treatment & Management Forecasted Market Size by Type (2025-2030)
5 Acute Kidney Injury Treatment & Management Breakdown Data by Application
5.1 Global Acute Kidney Injury Treatment & Management Historic Market Size by Application (2019-2024)
5.2 Global Acute Kidney Injury Treatment & Management Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acute Kidney Injury Treatment & Management Market Size (2019-2030)
6.2 North America Acute Kidney Injury Treatment & Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acute Kidney Injury Treatment & Management Market Size by Country (2019-2024)
6.4 North America Acute Kidney Injury Treatment & Management Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acute Kidney Injury Treatment & Management Market Size (2019-2030)
7.2 Europe Acute Kidney Injury Treatment & Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acute Kidney Injury Treatment & Management Market Size by Country (2019-2024)
7.4 Europe Acute Kidney Injury Treatment & Management Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acute Kidney Injury Treatment & Management Market Size (2019-2030)
8.2 Asia-Pacific Acute Kidney Injury Treatment & Management Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acute Kidney Injury Treatment & Management Market Size by Region (2019-2024)
8.4 Asia-Pacific Acute Kidney Injury Treatment & Management Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acute Kidney Injury Treatment & Management Market Size (2019-2030)
9.2 Latin America Acute Kidney Injury Treatment & Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acute Kidney Injury Treatment & Management Market Size by Country (2019-2024)
9.4 Latin America Acute Kidney Injury Treatment & Management Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Kidney Injury Treatment & Management Market Size (2019-2030)
10.2 Middle East & Africa Acute Kidney Injury Treatment & Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acute Kidney Injury Treatment & Management Market Size by Country (2019-2024)
10.4 Middle East & Africa Acute Kidney Injury Treatment & Management Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Company Detail
11.1.2 B. Braun Melsungen AG Business Overview
11.1.3 B. Braun Melsungen AG Acute Kidney Injury Treatment & Management Introduction
11.1.4 B. Braun Melsungen AG Revenue in Acute Kidney Injury Treatment & Management Business (2019-2024)
11.1.5 B. Braun Melsungen AG Recent Development
11.2 Baxter International, Inc.
11.2.1 Baxter International, Inc. Company Detail
11.2.2 Baxter International, Inc. Business Overview
11.2.3 Baxter International, Inc. Acute Kidney Injury Treatment & Management Introduction
11.2.4 Baxter International, Inc. Revenue in Acute Kidney Injury Treatment & Management Business (2019-2024)
11.2.5 Baxter International, Inc. Recent Development
11.3 Asahi Kasei Medical Co., Ltd
11.3.1 Asahi Kasei Medical Co., Ltd Company Detail
11.3.2 Asahi Kasei Medical Co., Ltd Business Overview
11.3.3 Asahi Kasei Medical Co., Ltd Acute Kidney Injury Treatment & Management Introduction
11.3.4 Asahi Kasei Medical Co., Ltd Revenue in Acute Kidney Injury Treatment & Management Business (2019-2024)
11.3.5 Asahi Kasei Medical Co., Ltd Recent Development
11.4 Angion Biomedica Corp
11.4.1 Angion Biomedica Corp Company Detail
11.4.2 Angion Biomedica Corp Business Overview
11.4.3 Angion Biomedica Corp Acute Kidney Injury Treatment & Management Introduction
11.4.4 Angion Biomedica Corp Revenue in Acute Kidney Injury Treatment & Management Business (2019-2024)
11.4.5 Angion Biomedica Corp Recent Development
11.5 AM-Pharma
11.5.1 AM-Pharma Company Detail
11.5.2 AM-Pharma Business Overview
11.5.3 AM-Pharma Acute Kidney Injury Treatment & Management Introduction
11.5.4 AM-Pharma Revenue in Acute Kidney Injury Treatment & Management Business (2019-2024)
11.5.5 AM-Pharma Recent Development
11.6 Quark Pharmaceuticals, Inc
11.6.1 Quark Pharmaceuticals, Inc Company Detail
11.6.2 Quark Pharmaceuticals, Inc Business Overview
11.6.3 Quark Pharmaceuticals, Inc Acute Kidney Injury Treatment & Management Introduction
11.6.4 Quark Pharmaceuticals, Inc Revenue in Acute Kidney Injury Treatment & Management Business (2019-2024)
11.6.5 Quark Pharmaceuticals, Inc Recent Development
11.7 Fresenius Medical Care AG & Co. KGaA
11.7.1 Fresenius Medical Care AG & Co. KGaA Company Detail
11.7.2 Fresenius Medical Care AG & Co. KGaA Business Overview
11.7.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment & Management Introduction
11.7.4 Fresenius Medical Care AG & Co. KGaA Revenue in Acute Kidney Injury Treatment & Management Business (2019-2024)
11.7.5 Fresenius Medical Care AG & Co. KGaA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
